China SXT Pharmaceuticals, Inc. SXTC
2.57
0.02
0.78%
as of 25 Sep
- Market cap
- $3.5M
- P/E
- 0.0×
Follow SXTC
| Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
143.50 | 143.50 | 101.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | (0.05) | (1.34) | (1.83) | (3.04) | (2.11) | (3.79) | (5.94) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 4.65 | 2.01 | 1.36 | 0.95 | 1.69 | 2.66 |
EV/Operating CF |
0.00 | 0.00 | (3.72) | 0.85 | 5.16 | 7.98 | 20.65 | 3.08 | 2.79 | 2.87 |
EV/FCF |
0.00 | 0.00 | (3.72) | 0.18 | 3.73 | 6.79 | 16.41 | 2.93 | 2.80 | 2.90 |
Quick Ratio |
1.07 | 0.78 | 2.13 | 0.97 | 0.96 | 1.10 | 1.29 | 1.50 | 3.30 | 7.17 |
Current Ratio |
1.37 | 1.40 | 2.47 | 1.60 | 1.25 | 1.31 | 1.35 | 1.60 | 3.54 | 7.93 |
Net Debt/EBITDA |
0.14 | (0.15) | (4.73) | 0.56 | 7.19 | 2.78 | 2.60 | 4.18 | 6.67 | 3.86 |
Debt/Assets |
5.56% | 5.03% | 0.40% | 30.98% | 0.13% | 6.10% | 11.68% | 10.43% | 3.73% | 2.88% |
Debt/Equity |
0.16 | 0.12 | 0.01 | 0.72 | 0.00 | 0.12 | 0.23 | 0.17 | 0.05 | 0.03 |
Asset Turnover |
0.83 | 1.07 | 0.56 | 0.26 | 0.17 | 0.08 | 0.06 | 0.07 | 0.08 | 0.04 |
Operating CF/Net income |
0.25 | 1.62 | 0.16 | (0.09) | 0.48 | (0.05) | 0.01 | 0.62 | 0.71 | 0.65 |
Capex/Depreciation |
(1.88) | (8.12) | (3.37) | (1.23) | (0.27) | (0.20) | (0.28) | (0.03) | 0.77 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 91.32% | 46.22% | 21.39% | (100.32%) | (21.67%) | (35.42%) | (38.15%) | (21.65%) | (22.50%) | (27.49%) | |
| 20.21% | 18.15% | 12.25% | (52.53%) | (9.77%) | (16.85%) | (18.81%) | (11.76%) | (14.75%) | (22.00%) | |
ROIC |
47.93% | 33.86% | 58.66% | (9.48%) | (51.90%) | (111.79%) | (453.09%) | (36.86%) | 0.00% | (175.91%) |
Return on Tangible Assets |
65.42% | 45.81% | 14.76% | (114.99%) | (45.15%) | (87.47%) | (99.13%) | (54.74%) | (21.37%) | (20.49%) |
Average Days of Receivables |
281.88 | 142.29 | 217.62 | 324.38 | 344.33 | 467.52 | 248.91 | 248.85 | 360.39 | 963.70 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
14.54% | 25.21% | 40.53% | 78.35% | 105.42% | 247.52% | 306.02% | 159.15% | 175.08% | 647.71% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 89.71% | 28.13% | 18.26% | 0.00% | 466.19% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
0.70% | 0.70% | 0.99% | 0.00% | 0.00% | (0.14%) | (0.13%) | (0.56%) | (0.37%) | (82.82%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.24 | 0.35 | 0.34 | 0.84 | 6.64 | 2.50 | 0.00 | 0.00 | 17,409.00 | 133.89 |
Operating CF per Share |
0.01 | 0.10 | 0.01 | 0.15 | (1.83) | 0.26 | 0.00 | 0.00 | (23,453.00) | (472.65) |
Capex per Share |
(0.01) | (0.05) | (0.03) | (0.07) | (0.13) | (0.06) | 0.00 | 0.00 | 635.00 | 0.00 |
Free Cash Flow per Share |
0.01 | 0.04 | (0.02) | 0.09 | (1.96) | 0.20 | 0.00 | 0.00 | (22,818.00) | (472.65) |
Cash per Share |
0.00 | 0.03 | 0.45 | 1.18 | 18.57 | 14.97 | 0.00 | 0.00 | 181,294.00 | 3,314.85 |
Shareholders Equity per Share |
0.09 | 0.16 | 0.54 | 1.52 | 22.18 | 15.79 | 0.00 | 0.00 | 154,398.00 | 3,494.99 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
Book value per Share |
0.09 | 0.16 | 0.54 | 1.52 | 22.18 | 15.79 | 0.00 | 0.00 | 154,398.00 | 3,494.99 |
Free Cash Flow |
0.11 | 0.87 | (0.37) | 0.53 | (1.41) | 0.21 | (0.15) | (1.94) | (2.28) | (4.02) |
Working Capital |
1.33 | 1.73 | 9.27 | 7.37 | 4.65 | 5.33 | 5.02 | 5.33 | 15.28 | 30.16 |
Capital Expenditures |
(0.19) | (1.05) | (0.61) | (0.41) | (0.09) | (0.06) | (0.07) | (0.01) | 0.06 | — |
Net Current Asset Value |
1.33 | 1.73 | 9.23 | 7.34 | 4.65 | 5.33 | 4.66 | 5.04 | 15.07 | 29.46 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.04 | 0.15 | 0.09 | 0.08 | 0.02 | 0.02 | 0.04 | 0.00 | (0.04) | 0.00 |
Net Profit Margin |
24.28% | 16.92% | 21.95% | (199.29%) | (57.52%) | (220.42%) | (301.00%) | (160.67%) | (189.77%) | (545.22%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.20 | 0.15 | 0.16 | 0.21 | 0.24 | 0.26 | 0.26 | 0.62 | 0.46 | 0.63 |
Cash ROIC |
(8.66%) | 24.43% | (4.49%) | (2.74%) | (9.37%) | (2.82%) | (2.94%) | (7.94%) | (7.34%) | (7.02%) |
Accounts Receivable Turnover |
1.25 | 2.16 | 2.03 | 1.18 | 1.05 | 0.66 | 0.84 | 1.45 | 1.15 | 0.48 |
Accounts Payable Turnover |
1.24 | 1.97 | 1.17 | 1.36 | 1.14 | 0.92 | 1.08 | 1.03 | 1.13 | 1.07 |
Inventory Turnover |
1.97 | 3.35 | 2.11 | 2.59 | 2.21 | 1.44 | 2.00 | 2.07 | 1.69 | 1.11 |
Average Days of Payables |
179.64 | 242.89 | 256.27 | 288.19 | 274.30 | 400.56 | 325.44 | 339.77 | 307.81 | 204.21 |
Days of Inventory on Hand |
126.54 | 127.82 | 153.25 | 132.54 | 161.91 | 274.98 | 125.49 | 211.09 | 220.06 | 318.91 |
Average Receivables |
3.92 | 3.25 | 3.46 | 4.38 | 4.55 | 3.92 | 2.34 | 1.33 | 1.52 | 2.36 |
Average Payables |
2.08 | 1.84 | 2.05 | 1.81 | 1.70 | 1.47 | 1.43 | 1.33 | 1.22 | 0.83 |
Average Inventory |
1.30 | 1.08 | 1.14 | 0.95 | 0.88 | 0.94 | 0.77 | 0.66 | 0.81 | 0.80 |
Average Assets |
5.86 | 6.54 | 12.56 | 19.59 | 28.12 | 34.05 | 31.55 | 26.34 | 22.40 | 28.21 |
Average Common Equity |
1.30 | 2.57 | 7.20 | 10.25 | 12.68 | 16.19 | 15.56 | 14.31 | 14.69 | 22.57 |
Columns are period end dates